Safety and efficacy of nintedanib in patients with idiopathic pulmonary fibrosis : A real life experience
Phase of Trial: Phase IV
Latest Information Update: 25 Jan 2017
At a glance
- Drugs Nintedanib (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Therapeutic Use
- 25 Jan 2017 New trial record.